🔎 Trials Near Me

Home › Neuroblastoma › Hawaii › Honolulu

Pag-aaral pangklinika para sa Neuroblastoma sa Honolulu, HI

6 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Honolulu (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Nagre-recruitPhase 3
  • Kapiolani Medical Center for Women and Children, Honolulu
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Nagre-recruitPhase 2
  • Kapiolani Medical Center for Women and Children, Honolulu
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Nagre-recruitPhase 1/2
  • Kapiolani Medical Center for Women and Children, Honolulu
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Nagre-recruitPhase 1/2
  • Kapiolani Medical Center for Women and Children, Honolulu
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Nagre-recruitPhase 2
  • Kapiolani Medical Center for Women and Children, Honolulu
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Nagre-recruitPhase 2
  • Kapiolani Medical Center for Women and Children, Honolulu
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887

Pag-aaral para sa Neuroblastoma sa ibang lungsod

Iba pang pag-aaral sa Honolulu

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.